Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 20Lymphoma, Mantle-Cell 13Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, B-Cell, Marginal Zone 7Leukemia, Lymphocytic, Chronic, B-Cell 7Lymphoma, Follicular 6Lymphoma, B-Cell 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Biphenotypic, Acute 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Leukemia, Hairy Cell 2Blast Crisis 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, T-Cell 1Lymphoma, AIDS-Related 1Leukemia, Prolymphocytic 1Leukemia, Myeloid, Chronic-Phase 1Hematopoietic and Lymphoid System Neoplasm 1Composite Lymphoma 1Classic Follicular Lymphoma 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

Vincristine 3Rituximab 3Prednisone 3Etoposide 3Doxorubicin 3Cyclophosphamide 3Filgrastim 2prednylidene 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1liposomal doxorubicin 1ibrutinib 1etoposide phosphate 1deltacortene 1Ultrasonography 1Lenalidomide 1Granulocyte Colony-Stimulating Factor 1Endoscopy 1Electrocardiography 1Echocardiography 1CT-P10 1Bronchoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, AIDS-Related × CT-P10 × 1 year × Clear all
NCT03220022 2026-04-13

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

National Cancer Institute (NCI)

Phase 1 Active not recruiting
46 enrolled 19 charts
Lymphoid

Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡